Company Filing History:
Years Active: 1996-1998
Title: Innovations by Thomas S. Kohlmann
Introduction
Thomas S. Kohlmann is an accomplished inventor based in McFarland, Wisconsin. He has made significant contributions to the field of medical technology, particularly in nitric oxide therapy. With a total of 2 patents, his work focuses on improving patient care through innovative delivery systems.
Latest Patents
Kohlmann's latest patents include a system for the pause control of nitric oxide therapy. This system allows healthcare providers to activate a pause mode through user input, enabling interventions without altering alarm settings or established flows. The CPU in the system recognizes the activation of the pause mode and sends a signal to close a valve, discontinuing the supply of nitric oxide. A timer is activated during this pause, ensuring that therapy can resume automatically after a predetermined period.
Another notable patent is the nitric oxide delivery system, which is compatible with various gas delivery systems. This system detects the flow of gas delivered to a patient and calculates the flow of nitric oxide in a diluent gas. It operates independently of the specific gas delivery system, allowing for flexibility in use while ensuring the desired concentration of nitric oxide is achieved.
Career Highlights
Kohlmann works at Ohmeda Inc., a company known for its advancements in medical gas delivery systems. His innovative contributions have played a crucial role in enhancing the safety and effectiveness of nitric oxide therapy for patients.
Collaborations
Throughout his career, Kohlmann has collaborated with notable colleagues, including Duncan P. Bathe and Robert Q. Tham. These partnerships have fostered a collaborative environment that encourages the development of groundbreaking medical technologies.
Conclusion
Thomas S. Kohlmann's work in nitric oxide therapy exemplifies the impact of innovation in healthcare. His patents reflect a commitment to improving patient outcomes through advanced technology. His contributions continue to shape the future of medical treatment.